table of content
Table of Contents
Post-pandemic Era-Global Nonalcoholic Steatohepatitis (NASH) Market Analysis 2022, With Top Companies, Sales, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Obeticholic acid?OCA? -Product Introduction and Major Company
1.1.2 Selonsertib -Product Introduction and Major Company
1.1.3 Emricasan -Product Introduction and Major Company
1.1.4 GR-MD-02 -Product Introduction and Major Company
1.1.5 IMM-124E -Product Introduction and Major Company
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Five-Year Compound Annual Growth Rate (CAGR)
2 Regional Market
2.1 Regional Market Share in Terms of Sales (2018 & 2022 & 2026)
2.2 Regional Market Share in Terms of Revenue (2018 & 2022 & 2026)
2.3 Regional Market Share in Terms of Consumption (2018 & 2022 & 2026)
3 Global Nonalcoholic Steatohepatitis (NASH) Market Assessment by Type
3.1 Global Nonalcoholic Steatohepatitis (NASH) Sales by Type (2018-2028)
3.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue by Type (2018-2028)
3.3 North America Nonalcoholic Steatohepatitis (NASH) Sales and Revenue by Type (2018-2028)
3.4 Asia Nonalcoholic Steatohepatitis (NASH) Sales and Revenue by Type (2018-2028)
3.5 Europe Nonalcoholic Steatohepatitis (NASH) Sales and Revenue by Type (2018-2028)
3.6 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Sales and Revenue by Type (2018-2028)
3.7 South America Nonalcoholic Steatohepatitis (NASH) Sales and Revenue by Type (2018-2028)
4 Historical & Forecast Global Nonalcoholic Steatohepatitis (NASH) Market Assessment by Application
4.1 Global Nonalcoholic Steatohepatitis (NASH) Consumption and Consumption in Different Application Field (2018-2028)
4.2 North America Nonalcoholic Steatohepatitis (NASH) Consumption and Consumption in Different Application Field (2018-2028)
4.3 Asia Nonalcoholic Steatohepatitis (NASH) Consumption and Consumption in Different Application Field (2018-2028)
4.4 Europe Nonalcoholic Steatohepatitis (NASH) Consumption and Consumption in Different Application Field (2018-2028)
4.5 Middle East & Africa Nonalcoholic Steatohepatitis (NASH) Consumption and Consumption in Different Application Field (2018-2028)
4.6 South America Nonalcoholic Steatohepatitis (NASH) Consumption and Consumption in Different Application Field (2018-2028)
5 North America
5.1 US Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
5.2 Canada Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
5.3 Mexico Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
6 Asia
6.1 China Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
6.2 Japan Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
6.3 India Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
6.4 Korea Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
6.5 Southeat Asia Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
7 Europe
7.1 Germany Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
7.2 UK Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
7.3 France Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
7.4 Russia Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
7.5 Italy Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
8 Middle East and Africa
8.1 Saudi Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
8.2 UAE Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
8.3 Egypt Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
8.4 Nigeria Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
8.5 South Africa Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
9 South America
9.1 Brazil Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
9.2 Argentina Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
9.3 Colombia Nonalcoholic Steatohepatitis (NASH) Sales, Revenue and Growth Rate (2018-2028)
10 Global Nonalcoholic Steatohepatitis (NASH) Average Price Trend
10.1 Market Price for Each Type of Nonalcoholic Steatohepatitis (NASH) in North America (2018-2028)
10.2 Market Price for Each Type of Nonalcoholic Steatohepatitis (NASH) in Asia (2018-2028)
10.3 Market Price for Each Type of Nonalcoholic Steatohepatitis (NASH) in Europe (2018-2028)
10.4 Market Price for Each Type of Nonalcoholic Steatohepatitis (NASH) in Middle East & Africa (2018-2028)
10.5 Market Price for Each Type of Nonalcoholic Steatohepatitis (NASH) in South America (2018-2028)
11 Value Chain
11.1 Nonalcoholic Steatohepatitis (NASH) Value Chain Analysis
11.1.1 Upstream
11.1.2 Downstream
11.2 COVID-19 Impact on Nonalcoholic Steatohepatitis (NASH) Industry
11.2.1 Industrial Policy Issued Under the Epidemic Situation
11.2.2 Post-pandemic Era
11.3 Cost-Under the Epidemic Situation
11.3.1 Cost of Raw Material
11.4 Channel Analysis
11.4.1 Distribution Channel-Under the Epidemic Situation
11.4.2 Distributors
12 Major Players of Global Nonalcoholic Steatohepatitis (NASH) Market, Competitive Analysis
12.1 Tobira Therapeutics
12.1.1 Tobira Therapeutics Company Profiles and Company News
12.1.2 Tobira Therapeutics Product Introduction
12.1.3 Tobira Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.1.4 SWOT Analysis
12.2 Cadila Healthcare
12.2.1 Cadila Healthcare Company Profiles and Company News
12.2.2 Cadila Healthcare Product Introduction
12.2.3 Cadila Healthcare Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.2.4 SWOT Analysis
12.3 Conatus Pharmaceuticals
12.3.1 Conatus Pharmaceuticals Company Profiles and Company News
12.3.2 Conatus Pharmaceuticals Product Introduction
12.3.3 Conatus Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.3.4 SWOT Analysis
12.4 Galmed Pharmaceuticals
12.4.1 Galmed Pharmaceuticals Company Profiles and Company News
12.4.2 Galmed Pharmaceuticals Product Introduction
12.4.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.4.4 SWOT Analysis
12.5 Novartis International
12.5.1 Gemphire Therapeutics Company Profiles and Company News
12.5.2 Gemphire Therapeutics Product Introduction
12.5.3 Gemphire Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.5.4 SWOT Analysis
12.6 Genfit
12.6.1 Genfit Company Profiles and Company News
12.6.2 Genfit Product Introduction
12.6.3 Genfit Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.6.4 SWOT Analysis
12.7 Gilead Sciences
12.7.1 Gilead Sciences Company Profiles and Company News
12.7.2 Gilead Sciences Product Introduction
12.7.3 Gilead Sciences Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.7.4 SWOT Analysis
12.8 Intercept Pharmaceuticals
12.8.1 Intercept Pharmaceuticals Company Profiles and Company News
12.8.2 Intercept Pharmaceuticals Product Introduction
12.8.3 Intercept Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.8.4 SWOT Analysis
12.9 Novartis International
12.9.1 Novartis International Company Profiles and Company News
12.9.2 Novartis International Product Introduction
12.9.3 Novartis International Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.9.4 SWOT Analysis
12.10 Takeda
12.10.1 Takeda Company Profiles and Company News
12.10.2 Takeda Product Introduction
12.10.3 Takeda Nonalcoholic Steatohepatitis (NASH) Sales, Revenue (2018-2022)
12.10.4 SWOT Analysis
13 Global Nonalcoholic Steatohepatitis (NASH) Market, Competitive Landscape and Market Forecast
13.1 Key Companies Dominating the Global Nonalcoholic Steatohepatitis (NASH) Market
13.2 Concentration Ratio (CR5) of Global Nonalcoholic Steatohepatitis (NASH) Market (2018)
13.2.1 Market Share of Top 5 Players in Term of Revenue (2018)
13.3 Concentration Ratio (CR5) of Global Nonalcoholic Steatohepatitis (NASH) Market (2022)
13.3.1 Market Share of Top 5 Players in Term of Revenue (2022)
14 Conclusion
15 Methodology and Data Source
